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ABSTRACT
Aim: Both Cathelicidin and Chemerin are chemo-attractant proteins and possess antimicrobial
activity. Sufficient level of Vitamin D is important for optimum response of Cathelicidin for its antimycobacterial activity. Studies on the role of these antimicrobial peptides and their relationship with
Vitamin D level are limited in tuberculosis. The aim of this study was to investigate an association
of Vitamin D with antimicrobial peptide (Cathelicidin) and an adipokine (Chemerin) in patients with
pulmonary tuberculosis (TB).
Methods: In a case control study we estimated level of Vitamin D, Chemerin, Cathelicidin and TNF
α in pulmonary TB patients (n=22) and healthy endemic controls (n=17) using sandwich ELISA
methodology. The study was conducted at Aga Khan University Karachi during 2011.
Results: TB group had higher proportion of subjects above median level of Cathelicidin (median
test; p=0.034) and fewer number of subjects with Chemerin (median test; p=0.001). Pairwise
comparison also showed significant differences between average ranks of Vitamin D vs.
Cathelicidin (p<0.0001), Chemerin vs. Cathelicidin (p=0.04) and Vitamin D vs. TNFα (p<0.0001).
Cathelicidin was identified as most discriminatory marker between TB disease and healthy group
(ROC, AUC 0.780; p=0.007).
Conclusion: Our results highlight the role of Cathelicidin as a potential biomarker of active TB
disease. The role of Cathelicidin and Chemerin as plausible biomarkers requires further studies in
both inflammatory and non-inflammatory conditions.

Keywords: Tuberculosis; vitamin D; cathelicidin; chemerin.

1. INTRODUCTION
Tuberculosis (TB) is the leading cause of
mortality and morbidity in developing world. In
2012, 0.5 million new incident cases were
reported in Pakistan with an incidence of
231/100,000 population [1]. Pakistan ranks 6th
among 22 highest TB burden countries [1].
Profound Vitamin D deficiency has been reported
among new incident TB cases [2] and healthy
volunteers in Pakistan [3]. Sufficient level of
Vitamin D is important for macrophage activation
for antimicrobial response [4]. The mechanism of
activation of macrophages via Vitamin D pathway
for anti-mycobacterial activity has already been
delineated [5]. The stimulation of Toll like
receptors (TLRs) on macrophages results in
activation of Cathelicidin gene (hCAP18) by 1hydroxylase enzyme gene (CYP27B1) [6] to
convert inactive Vitamin D [25(OH)D3] in to
active form [1,25-(OH)2D3]. A limited number of
studies have shown relationship of circulating
levels of inactive Vitamin D [25(OH)D3] and
Cathelicidin in clinical studies, such as TB [7]
and sepsis [8]. Cathelicidin family of peptides are
23-40 amino acid long chain with helical
structure. Cathelicidin possess antimicrobial
property because of its amphipathic topology and
presence of negatively charged residue.
Cathelicidin also up-regulates chemokine
receptors on macrophages [9] and is involved in
migration of immune cells to the site of infection.

Antimicrobial effect of Cathelicidin is very well
studied against M. tuberculosis (M.tb) [10].
However, the anti-mycobacterial effect of
Chemerin is not fully discovered. Chemerin is a
non-glycosylated 16 kDa protein secreted as
precursor of 143 amino acid residues known as
Prochem 163S. This multifunctional protein
primarily known for its adipokine and chemotactic
activity for immune cells [Plasmacytoid (PDCs),
NK and Macrophages)]. Proteolytic cleavage of
pro-chemerin molecule by cathepsin results in
formation of Chem 156 isoform which possess
greater affinity for chemokine receptor like 1
(CMKLR1). Chemerin is structurally similar to N
terminus Cathelin domain of human Cathelicidin.
The predominant function of Chemerin is glucose
homeostasis [11,12]. Due to its involvement in
regulation of immune cells and antimicrobial
activity, it is intriguing to address the association
of Chemerin with chronic inflammation such as
TB. Its association in diabetes and obesity has
already been established [13]. In countries with
high burden of TB, the rate of pre-diabetes and
Diabetes Mellitus (DM) is 24-25% among newly
diagnosed TB patients [14]. Animal models of
DM have also shown phenomenon of delayed
inflammatory response in granuloma formation
after aerosol challenge of M.tb [15,16]. The
relationship of low serum Vitamin D with
incidence of DM [17] has significantly move the
field to study the association of DM co-infected
with TB [18,19]. It is hypothesized that low serum
Vitamin D may promote pro-inflammatory
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cytokines milieu which is favorable for
progression of TB with or without comorbidity of
DM. It is therefore interesting to understand the
complex relationship of Chemerin (marker of
obesity and Diabetes) with
h Cathelicidin and
Vitamin D in TB patients. This relationship is
described in a conceptual diagram in Fig. 1.
The aim of our study is to assess the relationship
of two related chemoattractant peptides,
Cathelicidin and Chemerin with Vitamin D and
pro-inflammatory
nflammatory cytokine (TNFα) in TB cases
and healthy controls.

confirmed by chest X-ray,
ray, Acid Fast Bacilli (AFB)
sputum microscopy and history of TB symptoms.
Majority of TB patients had moderate (PMD)
(n=9) and, advanced (PAD) (n=7) pulmonary
disease, two patients were characterized as
minimal disease (PMD) and information was not
available for 3 patients. The severity of disease
classification
on was based on radiological findings,
and extent of lung tissue involvement as per
defined criteria [20]. Healthy endemic controls
(EC; n=17) had no history of TB exposure and
were recruited from administrative staff and
research technologists of AKU research and
teaching lab.

2. MATERIALS AND METHODS
2.1 Study Design
Twenty two (n=22) pulmonary TB patients (TB)
were recruited from The Aga Khan University
and Abbasi Shaheed Hospital outpatient clinics
in this case
se control study. The chest physicians
at both hospitals identified and referred the
pulmonary TB patients as per study inclusion and
exclusion criteria. Pulmonary disease was

Study protocol was approved by Ethical Review
Committee
ommittee (ERC) of Aga Khan University ((1689Path-ERC-10). All participants gave written
informed consent.
2.1.1 Inclusion criteria
The inclusion criteria for TB group (n=22) were
active pulmonary TB diagnosed as per WHO
guidelines [21]] within one month of treatment.

Fig. 1. Conceptual diagram of hypothetical
hypothetical relationship between vitamin D,
Cathelicidin and Chemerin
Low vitamin D i.e less than 20 ng/ml (A) triggers a pro
pro-inflammatory cytokine milieu,, which leads to chronic
inflammatory state (B). Reactivation
eactivation of latent TB infection
infec
due to immunosuppression and disturbance of Th1 and
Th2 cytokines axis may lead to progression of active disease (C), which is represented by elevated level of
Cathelicidin. Chronic inflammatory state may lead to dia
diabetes mellitus with or without co-incident
incident TB (D) which is
indicated by increase Chemerin level. The dashed arrow shows the relationship of Vitamin D to Chemerin
and Cathelicidin
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2.1.2 Exclusion criteria
Patients with treatment relapse or past TB
history, extra-pulmonary TB and known MDR TB
were not included in the study. TB patients with
prior
or
current
Vitamin
D
supplementation/injections, co-morbid conditions
such as DM, malignancies or auto immune
diseases were also excluded from the study.
Seventeen healthy controls were employees of
AKU. The inclusion criteria for healthy controls
(n=17) were no current or past TB diagnosis/DM/
chronic infections and no current or prior
intervention with Vitamin D. Healthcare workers
and lab staff directly exposed to TB were also
excluded.

2.2 Collection of Blood for Plasma and
Whole Blood Stimulation Assays
Five ml blood was collected in 15 ml of conical
tube (BD Falcon) containing sodium heparin (20
U/ml; Leo Pharmaceuticals, Ballerup, Denmark).
Heparinized blood was diluted 1:4 with RPMI
1640 (supplemented with Pen/Strep, 2 mM LGlutamine) for use in stimulation assays. Two ml
of blood was collected separately in EDTA tube
and centrifuged for 5 minutes at 2000 x g to
separate clear portion i.e. plasma within 2hrs of
collection. Plasma was stored in small aliquots
and kept at -70ºC until further use.
2.2.1 Preparation of active vitamin D [1, 25(OH) 2D3] for In vitro experiments
The 1, 25- (OH) 2D3 Vitamin D was purchased
from Sigma Chemicals (Sigma, St. Louis, USA).
The crystallized form of Vitamin D was dissolved
in reagent grade ethanol (EtOH) (Merck
laboratories). A ten-fold higher working stock for
each of the dilution was prepared to obtain a final
concentration 0.1 µM in 500µl of whole blood
cultures. The concentration of 1,25-(OH)2D3for
invitro experiments were consistent with previous
reports for stimulation of PBMCs [22] and
lympho-proliferative responses [23].
2.2.2 Stimulation of whole blood with active
vitamin D [1, 25-(OH) 2D3] for cytokine
secretion in supernatants
Stimulation of whole blood cultures with Vitamin
D [1, 25-(OH) 2D3]. The whole blood cultures
were stimulated with 0.1µMconcentration of 1,
25-(OH) 2D3 (Sigma, St, Louis USA) in 24 well
tissue culture plates (Flow laboratories, UK).

Tissue culture plates (24 wells) were preloaded
with 1, 25-(OH) 2D3 in 50µl volume. Ethanol was
allowed to evaporate, leaving 1, 25-(OH) 2D3 in
0.1µM concentration in a well followed by 500 µl
of diluted whole blood. The control well for
Vitamin D was EtOH (vehicle control).
Supernatants collected at day 1 and day 3 post
stimulation were stored as 4 x 100 microliters
aliquots in -80°C until use.
2.2.3 Assessment of cytokines (TNFα, IFN
and IL10) in stimulated whole blood
cultures and plasma
Cytokine assessment was carried out using pairs
of monoclonal antibodies from Endogen,
Rockford IL, USA. Protocols for cytokine
assessment have been described in detail
elsewhere [24]. Briefly, Immulon4 plates were
coated with capture antibodies overnight at 4°C.
Next day plates were blocked with BSA and
subsequently incubated with 100 µl of culture
supernatant. Revealing and probing antibodies
were added after appropriate incubation. All
probing antibodies were labeled with biotin and
revealing antibodies were labeled with avidin
bound to horse radish peroxidase (HRP). Finally
plates were developed with HRP substrate. All
plates were read on plate reader (Biorad, CA,
USA). Optical densities were read against known
concentration of standards (1000 pg-7.8 pg.) of
cytokines to determine the concentrations in test
samples [24].
2.2.4 Estimation of inactive form of vitamin D
[25(OH)D3] in plasma
Baseline Vitamin D levels were assessed in
plasma samples of TB patients and healthy
controls. Circulating Vitamin D was measured by
ELISA using the Immuno Diagnostic System Ltd
[IDS, Fountain Hill, AZ, USA]. All protocols were
followed according to manufacturer instructions.
Each test was run in duplicate, with mean
absorbance of test samples computed from the
average for two wells normalized for 0 calibrator
well. Concentrations of Vitamin D in test samples
were derived by fitting a 2 parameter logistic
curve to 6 standard concentrations, and was
expressed as ng/ml (1 nmol/L * 0.4= 1 ng/ml) [2].
2.2.5 Estimation of Cathelicidin peptide by
ELISA
Estimation of Cathelicidin peptide was carried out
by ELISA (Hycult Biotechnology, AA Uden The
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Netherlands) assay in plasma samples. All
protocols
were
followed
according
to
manufacturer instructions. Each sample was run
in duplicate. The minimum measurable
concentration was between 0.1 ng/ml to up to
100 ng/ml of Cathelicidin. The unknown
concentration
was
derived
by
plotting
absorbance of
samples
against known
concentrations of standards. All standard curve
has R2 greater than 0.90.
2.2.6 Estimation of Chemerin peptide by
ELISA
Chemerin levels in plasma samples were
determined using a commercially available
sandwich ELISA kit (Glory Bioscience, USA, cat
#11406). The inter-assay coefficient of variation
was less than 10%, and the within-assay
coefficient of variation was less than 5%. The
sensitivity of the ELISA assay was 0.5–10 ng/ml,
and the midrange of the assay was 5 ng/ml. The
least detectable concentration of human
Chemerin was 0.5 ng/ml.

2.3 Statistical Methods
Data was analyzed by statistical software of
SPSS 19 and Microsoft Excel. Mann Whitney U
test and Median test was applied for comparison
of median difference in two groups. Friedman
two way test was applied for comparison of ranks
between two analytes. ROC analysis was carried
out for identification of discriminatory marker
between TB and EC groups. A p value <0.05
was considered a significant between groups.

3. RESULTS AND DISCUSSION
3.1 Characteristics of the Study Groups
TB group comprised of (54%) of male and (45%)
female. The mean age of TB and EC groups
were 25.136±8.697yrs (range 16-50yrs), and
31.647±5.219yrs (24-46yrs) respectively. BCG
scar was present in 27% of TB patients and up to
90% in healthy controls. Overall incidence of HIV
in TB cases is 0.96% in Pakistan [1]. TB patients
were not screened for HIV positivity.

3.2 Relationship of circulating level of
Cathelicidin, Chemerin and Vitamin D
in TB and EC Group
The criteria for plasma Vitamin D [25(OH)D3]
deficiency is based on international convention
(reference plasma levels) (deficient = <20 ng/ml;

insufficient =21-29 ng/ml; sufficient >30 ng/ml)
[4]. A majority (71%; N= 28/39) of study
participants had deficient Vitamin D levels [<20
ng/ml of plasma 25(OH) D3].
Fig. 2 shows the comparison of Chemerin (Fig.
2a), Cathelicidin (Fig. 2b) Vitamin D (Fig. 2c) and
TNFα (Fig. 2d) between TB and EC groups in
box plots. In TB group, the level of Chemerin was
significantly lower compared to controls (p=0.02).
The average weight of TB patients was
41.22±3.77kg, and that of EC was 63.83±12.31
kg (T test; p=0.00004). The lower level of
Chemerin in TB group is presumably due to
lower body weight or less adipocytes.
We next compared the Cathelicidin and TNFα
among TB and EC group, the level of
Cathelicidin and TNFα are presumably higher in
TB patients, although the medians are not
significantly different. Cathelicidin and TNFα
showed similar trends in box plots which were
later confirmed by scatter plot that showed a
linear relationship (Fig. 4). There was no
difference in Vitamin D level between TB and EC
group.
In order to determine the pairwise comparison of
biomarkers, we performed rank order analysis of
whole study group to observe the trend of
markers across the board. Table 1 shows the
distribution of Cathelicidin, Chemerin and Vitamin
D using rank order test. The average rank for
Cathelicidin was 2.49 followed by 1.95 in
Chemerin and 1.57 in Vitamin D. The difference
between average ranks of Cathelicidin and
Chemerin are significantly different (p=0.04).
Similarly the average ranks of Vitamin D and
Cathelicidin are also significantly different
(p<0.0001). However, no such relationship was
observed between Vitamin D and Chemerin. We
also observed a higher average rank for TNF
cytokine (4.00) compared to other variables
(p<0.0001).
We next compared Cathelicidin and Chemerin
levels in TB and EC groups. For this analysis,
groups were divided in two categories of
>median and ≤ median values of Cathelicidin
(Fig 3A) and Chemerin (Fig 3B). The median
value of Cathelicidin was 42.74 (IQR: 32.12078.650) in total study subjects. Fourteen of
twenty two (14/22) (63.6%) TB patients had
Cathelicidin level greater than 42.74 ng/ml
compared to 5/17 (29.4%) of EC group. For
≤median category, 12/17(70%) of EC had less
than 42.72 ng/ml of Cathelicidin compared to
8/22 (36%) in TB (Median test; p=0.03).
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Fig. 2. Distribution of antimicrobial peptide (cathelicidin), adipokine
adipokine (chemerin),
vitamin D and TNF
TNF in TB and EC groups
Box plot shows the serum level of Chemerin
Chemerin(A), Cathelicidin(B),
(B), 25(OH)D3 (C), and TNFα (D) in TB and EC
th
th
groups. The results are shown as median, 25 and 75 percentiles. Asterisks and circles are shown as outliers.
The estimation of Chemerin, Cathelicidin and vitamin D in blood was carried out by commercial sandwich ELISA
kits. Vitamin D was estimated by inhibition ELISA technique whe
where as Cathelicidin and Chemerin was done by
regular ELISA. TNFα detection was carried out by in
in-house
house Sandwich ELISA using pairs of monoclonal
antibodies. Mann Whitney U test was applied for comparison of significant difference in two groups. P<0.05 was
considered significant

p

p

Fig. 3. Elevated level of Cathelicidin but not Chemerin in TB patients
The bar graph shows the proportion of TB and EC group in two categories of >
>median and<
< median of
Cathelicidin (A) and Chemerin (B). X-axis
axis sh
shows the median categories of Cathelicidin and chemerinin ng/ml and
Y-axis shows the % in each category. All details of experiments are same as of Fig. 2. Median test was applied to
test the proportion of subjects in two categories
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Table 1. Pairwise comparison of vitamin D, Cathelicidin, Chemerin and TNF in study
subjects (n=39)
Relationship between variables
i. Vitamin D- Chemerin
ii. Vitamin D- Cathelicidin
iii. Vitamin D-TNFiv. Chemerin- Cathelicidin
v. Chemerin-TNF
vi. Cathelicidin - TNF
#

Average rank
1.57-1.95
1.57-2.49
1.47-4.00
1.95-2.49
1.95-4.00
2.49-4.00

#

Significance
0.311
<0.0001
<0.0001
0.040
<0.0001
<0.0001

Friedman’s two-way analysis of variance by ranks

The median value of Chemerin was 17.24 (IQR:
10.13-54.34). TB group had 6/22(27%) of cases
above the median value compared to 13/17
(76%) of EC. For ≤ median category, 16/22
(72%) of TB had less than 17.24 ng/ml of
Chemerin compared to only 3/17 (18%) in EC
group (Median test, p=0.001). Median test for
Vitamin D was not significant as it was observed
that both groups were equally deficient for
Vitamin D. These results show non homogenous
distribution of two peptides in this study group.

3.3 Correlation of Peptides (Cathelicidin
and Chemerin) with Vitamin D and
TNFα
Fig. 4 shows the correlation of Vitamin D and
Cathelicidin (A), Chemerin and Cathelicidin (B),
TNFα and Cathelicidin (C) and TNFα and
Chemerin (D). There was a negative correlation
between Vitamin D and Cathelicidin (rho-0.189,
p=0.248) and Vitamin D and Chemerin (rho0.132, p=0.430). Chemerin and Cathelicidin also
showed no correlation (rho0.023, p=0.894).
However, the numbers are fewer to draw a
definitive conclusion about this relationship.
TNFα showed a trend of positive correlation with
Cathelicidin (rho0.367, p=0.033) and negative
correlation with Chemerin (rho-0.191, p=0.287)
and Vitamin D (rho-0.230, p=0.185). The trend
of positive correlation between TNFα and
Cathelicidin indicates simultaneous regulation of
both markers in inflammatory state.

3.4 ROC Analysis for Biomarker of TB
In order to assess the discriminatory power of
markers in TB vs. EC groups, we carried out
ROC analysis (Fig. 5). In ROC analysis,
Cathelicidin was identified as most discriminatory
marker with AUC of 0.780 (p=0.007), followed by
TNFα (AUC of 0.673 (p=0.097). Both Vitamin D
and Chemerin had no discriminatory power. This
further confirms no relationship of Cathelicidin

and Chemerin in TB disease. High level of
Cathelicidin in TB patient was also shown in
Fig. 2 with marginal significance compared to EC
group (p=0.06). Cathelicidin is also emerging as
a marker of acute inflammation in TB patients,
which was also confirmed by ROC analysis
(Fig. 5).
To confirm an anti-inflammatory role of Vitamin
D, we also performed whole blood stimulation
assay with active form of Vitamin D [1,25(OH)2D3]. For this analysis, study group was
divided in to three categories of Vitamin D and
effect of stimulation of active form of Vitamin D
was observed on IFNand IL10 cytokines. The
results of whole blood assay showed an up
regulation of IL-10 but not IFNin Vitamin D
deficient
group
(Wilcoxon;
p=0.04)
(suppl. Fig. 1).

4. DISCUSSION
The current study was carried out to delineate
the relationship of two chemotactic and antimicrobial peptides in TB and EC groups with
similar level of Vitamin D deficiency.
Chemerin and Cathelicidin have structural
homology at N terminus region of hCAP18 [25].
Both peptides are potent chemoattractant and
possess antimicrobial activity against microbes
[26]. The antibacterial activity was particularly
exhibited by truncated peptides, Chem S 157
(truncated bioactive Chemerin lacking 6 amino
acids) and S 155 against E. coli and K.
pneumoniae [26]. These peptides also possess
chemoattractant property for CMKLR1+ blood
cells. Chemerin has been identified as a marker
of pre-diabetic stage [27], whereas Cathelicidin
as a marker of acute inflammation and probable
biomarker of TB [28]. Vitamin D deficiency is
prevalent worldwide including Pakistan [2].
National Nutrition Survey of Pakistan 2011,
reported a widespread deficiency of Vitamin D in
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Fig. 4. Correlation of biomarkers
Correlations of biomarkers are shown in scatter plot. A) Vitamin D vs. Cathelicidin. B) Chemerin vs. Cathelicidin.
C) TNFα vs. Cathelicidin.. D) TNFα vs. Chemerin. Straight lines indicate linear relationship between biomarkers
and curve lines are 95% CI among points lie close to linear line. The open and filled circles indicate EC and TB
groups respectively

both pregnant and non-pregnant
pregnant women [29].
This deficiency was prevalent in both urban
(87.9%) and rural (84.2%) women of child
bearing
g age. Low serum Vitamin D was also
correlated with Cathelicidin in sepsis patients [8]
and TB patients with smear positivity but not with
over all vitamin D status [7].
The increasing evidence of Vitamin D deficiency
in both TB and diabetes has prompted us to
investigate the actual relationship of markers of
TB and Diabetes in context of Vitamin D. To our
knowledge, this is the first study in Pakistani
Pa
subjects delineating intricate relationship of
Cathelicidin level with Chemerin in context of
Vitamin D deficiency. The induction of
Cathelicidin is dependent on sufficient level of
active form of Vitamin D, which is also important
for anti-mycobacterial
terial activity of macrophages.
However, our results showed no linear

relationship between circulating inactive Vitamin
D [25(OH) D3] and Cathelicidin peptide
(Cathelicidin) (Fig. 4). This was also confirmed
by ROC analysis where Cathelicidin showed up
as a single marker to discriminate TB group from
healthy controls with 80% sensitivity and 40%
specificity. Cathelicidin is also emerging as a
new biomarker of TB disease [28
[28]. A nonlinear
relationship of Cathelicidin with Vitamin D was
also reported in TB patients, where high level of
Cathelicidin was associated with high AFB
positivity or disease severity [7]. Similar finding
was reported by Iacob et al. [30] in HCV infected
patients. The other reports had conflicting results
about correlation of Cathelicidin and Vitamin Din
healthy controls [31,32]. Dixon et al reported
positive correlation between Cathelicidin and
Vitamin D using <32 ng/ml cutoff in healthy
controls. In contrast to this, another report
showed a positive correlation with Vitamin D, and
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Figure 5

Fig. 5. ROC analysis of biomarkers
Receiver Operating Characteristic (ROC) analysis was performed on serum Chemerin (brown), TNFα
TNF (blue) and
vitamin D (green): TB (n=20) was compared using
us
control (n=17) as non-disease state. The coordinate line is
shown in yellow. The dotted line shows the arbitrary cutoff for sensitivity and specificity of Cathelicidin

a trend of age dependent decrease in
Cathelicidin. To confirm the
he role of Cathelicidin
as a marker of inflammation, we also looked at
TNFα in both study groups (TB and EC), which
showed a direct linear relationship with
Cathelicidin (Fig. 4D).

tissue and fibroblast [34]. Based on our results,
we speculate that inflammatory response of
Chemerin is primarily due to inflammation in
adipose tissue which differs from chronic
inflammation in TB patients as level of Chemerin
are significantly lower in lean TB group.

Due to the ubiquitous expression of Chemerin in
inflammatory and metabolic pathway, its
regulation is broadly classified as agonists for
nuclear receptors, and immuno-modulators
modulators for
chronic inflammation. The pathway of Chemerin
release is meant to be regulated by Vitamin D
receptor (VDR) [33]. An increase in expression of
Chemerin mRNA was observed when adipocytes
were treated with Vitamin D [34].
]. Furthermore,
high level of circulating immune mediator such as
Chemerin and VCAM are
re highly suggestive of
inflammatory response in obese children with
concurrent low vitamin D level [35].
]. Although our
results did not show such regulation of Chemerin
and Vitamin D in our TB group, as both groups
were deficient with Vitamin D but distribution of
Chemerin was not homogenous in these groups.
This relationship of Chemerin and Vitamin D
holds true in case of inflammation of adipose

In this study, we also studied the effect of
exogenous addition of the active form of Vitamin
D [1,25-(OH)2D3] in whole blood on the secretion
of IFNand IL-10. Exogenous active form of
Vitamin D stimulates anti-inflammatory
inflammatory cytokine
(IL-10)
10) and down regulates pro-inflammatory
pro
cytokine (IFN).
Since there was no difference in Vitamin D level,
therefore TB and EC group were pooled for
invitro experiment. In our in vitro experiments, we
found an anti-inflammatory
inflammatory effect of 1,25
1,25(OH)2D3, that enhances the secretion of IL-10,
IL
while having a negative or no effect on
IFNsecretion.
secretion. Bioactive Vitamin D[1,25
D[1,25-(OH)2
D3] has immunosuppressive effect on var
various
pro-inflammatory cytokines (IFNTNFα & IL12)
[22,36],
], and exerts its regulatory effect on T cells
via inhibition of DCs maturation [37].
[37
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The major limitation of our study was in
accessibility of TB patient with co-morbid of
Diabetes, which is critical to draw conclusion
about role of Chemerin in TB with DM. The
results of this study highlight the role of
Cathelicidin as biomarker of TB which is also
supported by concomitant increase in TNF in
TB patient but not with Vitamin D and Chemerin.
Vitamin D deficiency is prevalent in Pakistani
population. Both TB patients and EC are
deficient with circulating level of Vitamin D. This
is interesting to investigate what factors in
addition to Vitamin D increase susceptibility to
TB infection, such as genetic, environmental and
nutritional status.

5. CONCLUSION

3.

4.
5.

6.

7.

Our results show a trend of nonlinear relationship
of Cathelicidin and Chemerin in TB patients and
healthy controls (EC) without comorbidity of DM.
However, a linear relationship of Cathelicidin was
observed with TNFα but not with Chemerin and
Vitamin D. Cathelicidin was also identified as
most discriminatory marker of inflammation in TB
followed by TNFα. It is also important to study
the relationship of these two peptides in TB
patients with or without DM to further dissect the
role of Chemerin and Cathelicidin in TB disease,
and whether or not these markers can be used
for screening TB with DM.

8.

9.
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